uniQure’s gene therapy for Huntington’s disease holds blockbuster potential: GlobalData EP News Bureau Oct 7, 2025 GlobalData reports that uniQure’s AMT-130 shows disease-slowing potential in Huntington’s disease, though high costs, surgical…
Teva Pharm gets approval in China for Huntington’s treatment Reuters May 18, 2020 Austedo, the drug, was included in China’s fast-tracked approval channel as a rare disease treatment of “significant clinical…
Huntington’s Disease Market to reach $2.6 Billion by 2024: GlobalData Lakshmipriya Nair May 13, 2016 The Huntington’s disease pipeline will see exciting new developments over the next decade as disease-modifying drugs transform the…
